IUHSA
BOLD

Itau Unibanco Holding S.A.’s Audentes Therapeutics, Inc BOLD Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-336
Closed -$13K – 1028
2019
Q3 		$13K Hold
336
– – ﹤0.01% 278
2019
Q2 		$13K Sell
336
-457
-58% -$17.6K ﹤0.01% 583
2019
Q1 		$16K Hold
793
– – ﹤0.01% 567
2018
Q4 		$16K Sell
793
-128
-14% -$3.3K ﹤0.01% 567
2018
Q3 		$36K Sell
921
-21
-2% -$783 ﹤0.01% 557
2018
Q2 		$36K Sell
942
-7
-0.7% -$259 ﹤0.01% 640
2018
Q1 		$29K Buy
+949
New +$32.1K ﹤0.01% 511

Other funds holding BOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Itau Unibanco Holding S.A.'s BOLD Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Audentes Therapeutics, Inc (BOLD) in Q4 2019, closing a stake of 336 shares — an estimated $13K sold.

Itau Unibanco Holding S.A. first reported a position in BOLD in Q1 2018 and held it in 7 quarters. The position peaked at $36K in Q3 2018. 188 funds tracked by Wall St. Rank hold BOLD as of Q4 2019.

  • Itau Unibanco Holding S.A. reported no remaining Audentes Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 336 Audentes Therapeutics, Inc shares in Q4 2019, an estimated $13K.
  • Itau Unibanco Holding S.A. first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 7 quarters.
  • Itau Unibanco Holding S.A.'s Audentes Therapeutics, Inc position peaked at $36K in Q3 2018.
  • 188 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.